Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized pilot study of tacrolimus versus cyclophosphamide + prednisone in idiopathic membranous nephropathy
2007-005410-39Phase 2Active
- Sponsor
- Grupo Catalán de Estudio de Enfermedades Glomerulares
- Start
- Apr 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in idiopathic membranous glomerulonephritis (IMG) comparing Tacrolimus with Cyclophosphamide + prednisone (2 arms). Primary endpoints: Primary efficacy and safety comparison and Main efficacy variables. Started Apr 2008; status: active.
02
Drugs
tacrolimuscyclophosphamideprednisone
03
Conditions
idiopathic membranous glomerulonephritis (IMG)
Beyond the preview
Go deeper on 2007-005410-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005410-39.